Happy 1st anniversary to EICB, an initiative between BioLabs and Eisai It has been an incredible year supporting innovators at EICB. Look...

Japanese drugmaker Eisai, which operates a dementia-focused research facility in Cambridge, is hoping to tap into Greater Boston's...

CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd. and BioLabs announced...